Literature DB >> 19466516

The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery.

Kaoru Matsuura1, Mizuho Imamaki, Atsushi Ishida, Hitoshi Shimura, Masaru Miyazaki.   

Abstract

The effect of preoperative administration of aspirin on endothelial function in the patients undergoing off-pump coronary artery bypass (OPCAB) surgery is still unclear. Fifty consecutive patients undergoing OPCAB between May 2006 and May 2007 were equally divided into two groups - one without preoperative aspirin (group A; the first 25 patients) and the other with preoperative aspirin (group B; the next 25 patients). We investigated the degree of postoperative endothelial dysfunction by measuring the von Willebrand factor activity, which is a possible indicator of endothelial damage. The level of von Willebrand factor was not different between groups before surgery (group A 166% +/- 53% vs group B 181% +/- 62%; P = 0.39). Immediately after surgery it was significantly higher than before surgery in group A (231% +/- 79%; rate of increase 1.24 +/- 0.58), but not in group B (183% +/- 77%; rate of increase 1.03 +/- 0.55) (P < 0.02). The level was still significantly higher in group A than in group B on postoperative day 1 (group A 294 +/- 66 vs 254 +/- 51; P = 0.03), but there was no difference between groups on postoperative day 6. Although the frequency of blood transfusion was higher in group B, there was no difference in the amount of intraoperative bleeding between the groups. Preoperative use of aspirin before OPCAB could suppress the postoperative increase in von Willebrand factor, a possible indicator of endothelial damage, only in the early postoperative phase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466516     DOI: 10.1007/s00380-008-1105-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

1.  Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.

Authors:  Kevin A Bybee; Brian D Powell; Uma Valeti; A Gabriela Rosales; Stephen L Kopecky; Charles Mullany; R Scott Wright
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 2.  Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.

Authors:  Deepak L Bhatt; Sary Aranki; John Byrne; Devinder Bhatia; Shamir Mehta; Roger Mills
Journal:  J Invasive Cardiol       Date:  2005-05       Impact factor: 2.022

3.  Evaluation of platelet function in aspirin treated patients with CAD.

Authors:  Marlene S Williams; Thomas S Kickler; Dhananjay Vaidya; Ladina S Ng'alla; David E Bush
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

4.  Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.

Authors:  Aun Yeong Chong; Gregory Y H Lip; Bethan Freestone; Andrew D Blann
Journal:  Eur J Heart Fail       Date:  2005-09-26       Impact factor: 15.534

5.  Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway.

Authors:  S Oberle; T Polte; A Abate; H P Podhaisky; H Schröder
Journal:  Circ Res       Date:  1998-05-18       Impact factor: 17.367

Review 6.  Platelet inhibitor agents in cardiovascular disease: an update.

Authors:  B Stein; V Fuster; D H Israel; M Cohen; L Badimon; J J Badimon; J H Chesebro
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

7.  Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass.

Authors:  L Bec; M A Karolczak; B Motylewicz; E Rogala
Journal:  J Cardiovasc Surg (Torino)       Date:  2006-04       Impact factor: 1.888

8.  Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1.

Authors:  A López-Farré; C Caramelo; A Esteban; M L Alberola; I Millás; M Montón; S Casado
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

9.  Multiple off-pump coronary revascularization with "aorta no-touch " technique using composite and sequential methods.

Authors:  Junjiro Kobayashi; Yoshikado Sasako; Ko Bando; Kazuo Niwaya; Osamu Tagusari; Hiroyuki Nakajima; Yoshitsugu Nakamura; Michiko Ishida; Soichiro Kitamura
Journal:  Heart Surg Forum       Date:  2002       Impact factor: 0.676

10.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11
View more
  6 in total

1.  Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: a prospective study.

Authors:  Abdalla Awidi; Akram Saleh; Manar Dweik; Baraah Kailani; Mohammed Abu-Fara; Rinad Nabulsi; Abdulbari Bener
Journal:  Heart Vessels       Date:  2010-12-23       Impact factor: 2.037

2.  Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.

Authors:  Mate Petricevic; Bojan Biocina; Sanja Konosic; Tomislav Kopjar; Nino Kunac; Hrvoje Gasparovic
Journal:  Heart Vessels       Date:  2011-12-28       Impact factor: 2.037

3.  Preoperative aspirin resistance does not increase myocardial injury during off-pump coronary artery bypass surgery.

Authors:  Hyun Joo Kim; Jung-Man Lee; Jeong Hwa Seo; Jun-Hyeon Kim; Deok-Man Hong; Jae-Hyon Bahk; Ki-Bong Kim; Yunseok Jeon
Journal:  J Korean Med Sci       Date:  2011-07-27       Impact factor: 2.153

4.  Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins.

Authors:  Yuta Kato; Atsushi Iwata; Makito Futami; Motoki Yamashita; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer.

Authors:  Fariha Kanwal; Mingming Ma; Muhammad Fayyaz Ur Rehman; Fahim-Ullah Khan; Shai E Elizur; Aima Iram Batool; Chi Chiu Wang; Tahira Tabassum; Changrui Lu; Yao Wang
Journal:  Front Mol Biosci       Date:  2022-01-28

6.  Preparation and characterization of a novel aspirin derivative with anti-thrombotic and gastric mucosal protection properties.

Authors:  Xi-E Zhen; Ming Zong; Sai-Nan Gao; Yong-Gang Cao; Lei Jiang; Shu-Xin Chen; Kuan Wang; Shi-Qin Sun; Hai-Sheng Peng; Yu-Hua Bai; Sen Li
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.